abstract |
The present invention relates to a novel pharmaceutical composition of general formula (I) comprising a thienopyrimidine compound. Furthermore, the present invention provides a book for the manufacture of a pharmaceutical composition for the prevention and / or treatment of diseases that can be influenced by inhibiting the kinase activity of Mnk1 and / or Mnk2 (Mnk2a or Mnk2b) and / or variants thereof. It relates to the use of the thienopyrimidine compounds of the invention. |